Loratadine transdermal device and methods
US9259397B2 · kind B2 · utility
0Cited by
11References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 2001 |
| Grant date | Feb 16, 2016 |
| Priority date | — |
| Expiry date | Sep 4, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A tansdermal delivery device for effectively treating seasonal allergic rhinitis and chronic idiopathic urticariain in humans is disclosed and methods thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.